Contract facts
NONENo full NAICS 621991 intel page yet. Browse NAICS intelligence
MULTIPLE BLOOD PRODUCTS is a federal NONE award for Defense Health Agency held by American National Red Cross, the. Estimated value $1.5M ($1.5M obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: FALLS CHURCH VA.
Recompete timing
PublicCurrent PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordAmerican National Red Cross, the — $80.4M obligated across 322 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT001126FE010?
HT001126FE010 (Multiple BLOOD products) is a Defense Health Agency award with a potential value of $1.5M, currently held by American National Red Cross, the. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded HT001126FE010?
Defense Health Agency awarded HT001126FE010 to American National Red Cross, the (potential $1.5M).
Who is the incumbent on HT001126FE010?
American National Red Cross, the is the incumbent with $80.4M across 322 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.
When does American National Red Cross, the’s HT001126FE010 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.